当前位置: 首页 > 期刊 > 《医学信息》 > 20206
编号:13507528
早期应用不同剂量舍曲林干预脑梗死患者卒中后抑郁效果观察(3)
http://www.100md.com 2020年2月12日 《医学信息》 20206
     [1]Zhang T,Wang C,Liu L,et al.A prospective cohort study of the incidence and determinants of post-stroke depression among the mainland Chinese patients[J].Neurol Res,2010,32(4):347-352.

    [2]Zhang N,Wang CX,Wang AX,et al.Time course of depression and one-year prognosis of patients with stroke in mainland China[J].CNS Neurosci Ther,2012,18(6):475-481.

    [3]Razmara A,Valle N,Markovic D,et al.Depression Is Associated with a Higher Risk of Death among Stroke Survivors[J].J Stroke Cerebrovasc Dis,2017,26(12):2870-2879.

    [4]苑杰,王萌,郭鑫,等.氟西汀对卒中后抑郁的预防作用[J].中华行为医学与脑科学杂志,2016,25(10):953-957.

    [5]Villa RF,Ferrari F,Moretti A.Post-stroke depression:Mechanisms and pharmacological treatment[J].Pharmacol Ther,2018(184):131-144.

    [6]Rasmussen A,Lunde M,Poulsen DL,et al.A double-blind,placebo-controlled study of sertraline in the prevention of depression in stroke patients[J].Psychosomatics,2003,44(3):216-221.

    [7]Salter KL,Foley NC,Zhu L,et al.Prevention of poststroke depression: does prophylactic pharmacotherapy work?[J].J Stroke Cerebrovasc Dis,2013,22(8):1243-1251.

    收稿日期:2019-10-18;修回日期:2019-12-04

    編辑/李国苗, 百拇医药(叶欢 周华 沈蓉)
上一页1 2 3